Can Endoscopic Procedure Slow Post- GLP-1 Weight Rebound?

(MedPage Today) -- An investigational endoscopic procedure showed a trend for reducing weight rebounds after patients with obesity discontinued the GLP-1 agonist tirzepatide (Zepbound), according to preliminary results from the REMAIN-1 trial...
Source
MedPage Today
Opens original article in a new tab



